{
  "openalex_id": "W4251731166",
  "doi": "https://doi.org/10.1158/1538-7445.am2019-2214",
  "title": "Abstract 2214: Development and validation of PredicineATLAS, a 600-gene liquid biopsy panel for simultaneous detection of TMB and genomic alterations in Immuno-Oncology",
  "abstract": "Abstract Introduction: Tumor mutation burden (TMB) is a measurement of the number of somatic mutations carried by tumor cells. Microsatellite instability (MSI) reflects the genetic hypermutability. Both TMB and MSI have been shown to be effective genomic biomarkers for predicting response to anti PD-1/PD-L1 immunotherapy. Whole exome sequencing (WES) is a traditional means to estimate TMB and MSI from tumor tissue, however, it is challenging to translate it into blood or urine due to its high expense and low tumor cell percentage. In the present study, we developed a 600-gene liquid biopsy TMB panel, PredicineATLAS, to measure genomic alterations and estimate TMB and MSI using human body fluids. Methods: The PredicineATLAS panel contains 600 genes and covers 2.4Mb genomic regions (1.4 Mb of exonic coding regions). It was specifically designed for immuno-oncology, covering comprehensive immune- and cancer-related genes, biomarkers and MSI sites that are associated with anti PD-1/L1 therapy response. Reference materials with known genomic alterations and tumor cell lines were titrated with different concentrations to mimic different tumor contents for TMB and MSI measurement. Matched tissue and blood were used in validation study. Results: PredicineATLAS panel-based TMB strongly correlated with the WES-TMB using TCGA dataset. Analytical validation showed that PredicineATLAS NGS assay is highly robust and sensitive for detection of genomic alterations. Using matched tissue and blood sample set, blood-based PredicineATLAS panel-TMB and MSI correlate with its counterpart derived from tissue WES. Conclusions: PredicineATLAS liquid biopsy assay was developed and validated using reference materials and clinical samples. It detects genomic alterations and accurately estimate TMB and MSI, providing valuable genomic information to guide immuno-oncology therapy and clinical drug development. Citation Format: Zhixin Zhao, Amy Chang, Tak Cheung, Feng Xie, Carlos Montesinos, Amy Xiaohong Wang, Kemin Zhou, Shidong Jia, JIanjun Yu, Pan Du. Development and validation of PredicineATLAS, a 600-gene liquid biopsy panel for simultaneous detection of TMB and genomic alterations in Immuno-Oncology [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2019; 2019 Mar 29-Apr 3; Atlanta, GA. Philadelphia (PA): AACR; Cancer Res 2019;79(13 Suppl):Abstract nr 2214.",
  "authors": [
    {
      "display_name": "Zhixin Zhao",
      "id": "A5100706797",
      "orcid": "https://orcid.org/0000-0002-4989-1399",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Zhixin Zhao"
    },
    {
      "display_name": "Amy Chang",
      "id": "A5086302132",
      "orcid": "https://orcid.org/0000-0003-3682-6456",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Amy Chang"
    },
    {
      "display_name": "Tak Cheung",
      "id": "A5112294008",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Tak Cheung"
    },
    {
      "display_name": "Feng Xie",
      "id": "A5015716999",
      "orcid": "https://orcid.org/0000-0002-0215-667X",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Feng Xie"
    },
    {
      "display_name": "Carlos Montesinos",
      "id": "A5020680593",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Carlos Montesinos"
    },
    {
      "display_name": "Amy Xiaohong Wang",
      "id": "A5032977533",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Amy Xiaohong Wang"
    },
    {
      "display_name": "Kemin Zhou",
      "id": "A5102475247",
      "orcid": null,
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Kemin Zhou"
    },
    {
      "display_name": "Shidong Jia",
      "id": "A5077970099",
      "orcid": "https://orcid.org/0000-0001-5854-819X",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Shidong Jia"
    },
    {
      "display_name": "Jianjun Yu",
      "id": "A5100639000",
      "orcid": "https://orcid.org/0000-0001-9434-088X",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "JIanjun Yu"
    },
    {
      "display_name": "Pan Du",
      "id": "A5100620404",
      "orcid": "https://orcid.org/0000-0001-7335-4078",
      "institutions": [],
      "is_corresponding": false,
      "raw_author_name": "Pan Du"
    }
  ],
  "publication_year": 2019,
  "publication_date": "2019-07-01",
  "type": "article",
  "cited_by_count": 1,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S168522863",
    "display_name": "Cancer Research",
    "issn_l": "0008-5472",
    "issn": [
      "0008-5472",
      "1538-7445"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310320273"
  },
  "volume": "79",
  "issue": "13_Supplement",
  "first_page": "2214",
  "last_page": "2214",
  "open_access": {
    "is_oa": false,
    "oa_status": "closed",
    "oa_url": null,
    "any_repository_has_fulltext": false
  },
  "concepts": [
    {
      "id": "C2779529041",
      "display_name": "Liquid biopsy",
      "level": 3,
      "score": 0.7158439
    },
    {
      "id": "C2779767149",
      "display_name": "Microsatellite instability",
      "level": 5,
      "score": 0.59361017
    },
    {
      "id": "C502942594",
      "display_name": "Cancer research",
      "level": 1,
      "score": 0.4768775
    },
    {
      "id": "C2780352672",
      "display_name": "Bladder cancer",
      "level": 3,
      "score": 0.45138603
    },
    {
      "id": "C134305767",
      "display_name": "Somatic cell",
      "level": 3,
      "score": 0.44209236
    },
    {
      "id": "C121608353",
      "display_name": "Cancer",
      "level": 2,
      "score": 0.43107823
    },
    {
      "id": "C2775934546",
      "display_name": "Biopsy",
      "level": 2,
      "score": 0.42693257
    },
    {
      "id": "C104317684",
      "display_name": "Gene",
      "level": 2,
      "score": 0.42302456
    },
    {
      "id": "C86803240",
      "display_name": "Biology",
      "level": 0,
      "score": 0.3939159
    },
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.3849801
    },
    {
      "id": "C70721500",
      "display_name": "Computational biology",
      "level": 1,
      "score": 0.35048348
    },
    {
      "id": "C142724271",
      "display_name": "Pathology",
      "level": 1,
      "score": 0.28772813
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.28661054
    },
    {
      "id": "C61320498",
      "display_name": "Microsatellite",
      "level": 4,
      "score": 0.1954186
    },
    {
      "id": "C54355233",
      "display_name": "Genetics",
      "level": 1,
      "score": 0.18441597
    },
    {
      "id": "C180754005",
      "display_name": "Allele",
      "level": 3,
      "score": 0.0
    }
  ],
  "topics": [
    {
      "id": "T11287",
      "display_name": "Cancer Genomics and Diagnostics",
      "score": 0.9988
    },
    {
      "id": "T11297",
      "display_name": "Ferroptosis and cancer prognosis",
      "score": 0.9792
    },
    {
      "id": "T11369",
      "display_name": "Genetic factors in colorectal cancer",
      "score": 0.9726
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.1158/1538-7445.am2019-2214",
  "pdf_url": null,
  "retrieved_date": "2025-07-30T16:02:07.537071",
  "source_database": "OpenAlex"
}